Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies on tumor induced angiogenesis.

J L Ambrus1, C M Ambrus, P Forgach

  • 1Roswell Park Cancer Institute, State University of New York, Buffalo.

EXS
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased retention of tau PET ligand [<sup>18</sup>F]-AV1451 in Alzheimer's Disease Psychosis.

Translational psychiatry·2022
Same author

A price tag on clinical empathy? Factors influencing its cost-effectiveness.

Journal of the Royal Society of Medicine·2020
Same author

Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic <i>Escherichia coli</i> as a prophylactic against diarrhea.

Gut microbes·2020
Same author

Ethical, moral, and theological insights into advances in male pediatric and adolescent fertility preservation.

Andrology·2017
Same author

Trainee perspectives on postdoctoral recruitment in clinical neuropsychology: reflections on commentaries by Bodin and Grote (2016) and Nelson et al. (2016).

The Clinical neuropsychologist·2017
Same author

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.

The British journal of dermatology·2015

This study explored angiogenesis inhibitors, finding pentoxifylline (Px) and sodium diethyldithiocarbamate (DDTC) reduced tumor growth and metastasis in animal models. These agents show promise for anti-angiogenic cancer therapy.

Area of Science:

  • Oncology
  • Vascular Biology
  • Pharmacology

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
  • Platelet-derived growth factor (PDGF) plays a role in angiogenesis.
  • Developing effective anti-angiogenic therapies is a key goal in cancer treatment.

Purpose of the Study:

  • To evaluate the anti-angiogenic potential of various biologic agents.
  • To investigate the efficacy of pentoxifylline (Px) and sodium diethyldithiocarbamate (DDTC) in inhibiting tumor-induced angiogenesis and metastasis.
  • To explore synergistic effects between anti-angiogenic agents.

Main Methods:

  • Development of methods to test angiogenic response in rabbit and non-human primate corneas.
  • Administration of crude and purified PDGF preparations.

Related Experiment Videos

  • Testing of pentoxifylline (Px), sodium diethyldithiocarbamate (DDTC), epsilon amino caproic acid (EACA), and tranaxamic acid (t-AMCHA) in various murine tumor models.
  • Assessment of tumor implant-induced angiogenesis and spontaneous metastases.

    • Main Results:

    • Crude PDGF demonstrated angiogenic effects.
    • Purified PDGF also showed angiogenic properties.
    • Pentoxifylline (Px) inhibited tumor-induced angiogenesis and reduced spontaneous metastases in three out of four tested murine tumors.
    • Sodium diethyldithiocarbamate (DDTC) exhibited anti-angiogenic activity and potentiated the effect of Px.
    • Anti-fibrinolytic agents EACA and t-AMCHA were also anti-angiogenic.
    • DDTC and Px showed synergistic anti-angiogenic effects.

    Conclusions:

    • Pentoxifylline (Px) and sodium diethyldithiocarbamate (DDTC) are effective inhibitors of tumor angiogenesis and metastasis in specific preclinical models.
    • DDTC potentiates the anti-angiogenic effects of Px, suggesting potential for combination therapy.
    • Further research into these agents could lead to novel anti-angiogenic cancer treatments.